Thursday 16 April 2026

The Pharmaletter

Scorpion Therapeutics

A private biotech company developing small molecule precision oncology therapies

Company Overview

Want to Update your Company's Profile?


Latest Scorpion Therapeutics News

Lilly takes a nibble at Scorpion program
14 January 2025
$150 million Series C sets up Scorpion for next stage of growth
17 July 2024
ASCO Q&A: Pierre Fabre's focus on oncology gains momentum
3 June 2024
British drug discovery firm to work with Pierre Fabre in oncology
25 September 2023
More Scorpion Therapeutics news >


Today's issue

Yvonne McGrath named CSO at Enodia
Biotechnology
Yvonne McGrath named CSO at Enodia
15 April 2026
Biotechnology
Beeline Medicines debuts with BMS-derived pipeline
15 April 2026
Pharmaceutical
J&J beats estimates and raises forecast
15 April 2026
Pharmaceutical
Neffy approved as the first needle-free anaphylaxis treatment in Canada
15 April 2026
Pharmaceutical
FDA demands trial safety data on Foundayo after approval
15 April 2026
Pharmaceutical
Rubicon enters Indian CNS formulations market with buy of Arinna Lifesciences
15 April 2026
Biotechnology
Obsidian and Galera reveal reverse merger plan
15 April 2026




Copyright © The Pharma Letter 2026

 |  Headless Content Management with Blaze